Node-Sparing Hypofractionated Radiotherapy Plus Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Randomized, Phase II Trial

NCT07230639 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Neoadjuvant Therapies
Immune Checkpoint Therapy
Radiotherapy

Interventions

COMBINATION_PRODUCT: Node-Sparing Radiotherapy(25Gy/5F) plus Chemotherapy and PD-1 inhibitor
COMBINATION_PRODUCT: Node-Sparing Radiotherapy(24Gy/4F) plus Chemotherapy and PD-1 inhibitor

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University